Collegium Pharmaceutical (COLL) Other financing activities (2014 - 2026)

Collegium Pharmaceutical's Other financing activities history runs 13 years deep, the most recent figure standing at $947000.0 for Q1 2026.

• On a quarterly basis, Other financing activities fell 38.98% year-over-year to $947000.0 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 81.66% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 417.53% from the prior year.
• Other financing activities fell to $947000.0 in Q1 2026 per COLL's latest filing, from $2.9 million in the prior quarter.
• Across five years, Other financing activities topped out at $9.6 million in Q2 2024 and bottomed at -$9.2 million in Q4 2024.
• The 5-year median for Other financing activities is $356000.0 (2024), against an average of $1.0 million.
• Across the five-year window, Other financing activities slumped 433.76% in 2022 and jumped 335.96% in 2025, its largest moves.
• Year by year, Other financing activities stood at -$4.5 million in 2022, then surged by 172.5% to $3.2 million in 2023, then sank by 385.37% to -$9.2 million in 2024, then surged by 131.55% to $2.9 million in 2025, then tumbled by 67.54% to $947000.0 in 2026.
• Per Business Quant, the three latest COLL Other financing activities figures stand at $947000.0 (Q1 2026), $2.9 million (Q4 2025), and -$497000.0 (Q3 2025).